AbbVie Total Cost of Revenue decreased by 14.2% to $4.55B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 3.5%, from $4.40B to $4.55B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows relatively stable performance with a 1.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue may indicate rising component costs or manufacturing inefficiencies, whereas a decrease suggests better economies of scale.
The direct costs attributable to the production of the goods sold and the delivery of services. This typically encompass...
In the consumer electronics industry, this is often compared against revenue to determine the efficiency of the supply chain.
is_total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.52B | $4.39B | $4.32B | $4.05B | $4.17B | $5.02B | $4.17B | $3.99B | $4.24B | $6.49B | $5.70B | $4.09B | $4.20B | $4.21B | $4.40B | $4.00B | $4.35B | $5.30B | $4.55B |
| QoQ Change | — | -2.9% | -1.6% | -6.2% | +2.9% | +20.4% | -17.0% | -4.4% | +6.4% | +52.9% | -12.0% | -28.2% | +2.6% | +0.2% | +4.4% | -9.0% | +8.6% | +22.0% | -14.2% |
| YoY Change | — | — | — | — | -7.8% | +14.4% | -3.5% | -1.6% | +1.7% | +29.1% | +36.8% | +2.7% | -0.9% | -35.1% | -22.9% | -2.2% | +3.4% | +25.9% | +3.5% |
We use cookies for analytics. See our Privacy and Cookie Policy.